Slee, April

Pharmacological treatments for generalised anxiety disorder: A systematic review and network meta-analysis

Slee, A., Nazareth, I., Bondaronek, P., Liu, Y., Cheng, Z., & Freemantle, N. (2019) · The Lancet

Anxiety, Depression, Psychometrics, Treatment, Cognitive ProcessesTreatment of Major Depression

Cited by 372

Modafinil for the treatment of cocaine dependence

Anderson, A. L., Reid, M. S., Li, S.-H., Holmes, T., Shemanski, L., Slee, A., Smith, E. V., Kahn, R., Chiang, N., Vocci, F., et al. (2009) · Drug and Alcohol Dependence

Substance Abuse Treatment and OutcomesNeurotransmitter Receptor Influence on Behavior

Cited by 235

Relationship of Lipoproteins to Cardiovascular Events

Guyton, J. R., Slee, A. E., Anderson, T., Fleg, J. L., Goldberg, R. B., Kashyap, M. L., Marcovina, S. M., Nash, S. D., O'Brien, K. D., Weintraub, W. S., et al. (2013) · Journal of the American College of Cardiology

Lipoproteins and Cardiovascular HealthDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 182

Quality of Publicly Available Physical Activity Apps: Review and Content Analysis

Bondaronek, P., Alkhaldi, G., Slee, A., Hamilton, F. L., & Murray, E. (2018) · JMIR mHealth and uHealth

Mobile Health and mHealth ApplicationsDigital Mental Health Interventions

Cited by 156

The Effect of Canagliflozin, a Sodium Glucose Cotransporter 2 Inhibitor, on Glycemic End Points Assessed by Continuous Glucose Monitoring and Patient-Reported Outcomes Among People With Type 1 Diabetes

Rodbard, H. W., Peters, A. L., Slee, A., Cao, A., Traina, S. B., & Alba, M. (2017) · Diabetes Care

Diabetes Management and ResearchDiabetes Treatment and Management

Cited by 94

Surfactant therapy for COVID-19 related ARDS: a retrospective case–control pilot study

Piva, S., DiBlasi, R. M., Slee, A. E., Jobe, A. H., Roccaro, A. M., Filippini, M., Latronico, N., Bertoni, M., Marshall, J. C., & Portman, M. A. (2021) · Respiratory Research

Respiratory Support and MechanismsNeonatal Respiratory Health Research

Cited by 70

Effects of canagliflozin on serum potassium in the CANagliflozin cardioVascular Assessment Study (CANVAS) Program

Weir, M. R., Slee, A., Sun, T., Balis, D., Oh, R., de Zeeuw, D., & Perkovic, V. (2021) · Clinical Kidney Journal

Diabetes Treatment and ManagementPotassium and Related Disorders

Cited by 31